<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Techno Trends - Trending Technology On Pharmaceutical Industry</title>
	<atom:link href="https://www.worldpharmatoday.com/techno-trends/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Sat, 27 Jun 2026 07:52:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.worldpharmatoday.com/wp-content/uploads/2025/12/cropped-World-Pharma-Today-fevicon-32x32.jpg</url>
	<title>Techno Trends - Trending Technology On Pharmaceutical Industry</title>
	<link>https://www.worldpharmatoday.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>In Vivo CAR-T Engineering Sets a New Oncology Standard</title>
		<link>https://www.worldpharmatoday.com/drug-research/in-vivo-car-t-engineering-sets-a-new-oncology-standard/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:52:49 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/in-vivo-car-t-engineering-sets-a-new-oncology-standard/</guid>

					<description><![CDATA[<p>The emergence of chimeric antigen receptor T cell therapy has been one of the most significant breakthroughs in the history of hematology oncology. By re engineering a patient’s own immune cells to recognize and attack cancer, researchers have achieved unprecedented remission rates in patients with advanced leukemias and lymphomas. However, the current generation of CAR-T [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/in-vivo-car-t-engineering-sets-a-new-oncology-standard/">In Vivo CAR-T Engineering Sets a New Oncology Standard</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Proximity Therapeutics Unlock New Druggable Frontiers</title>
		<link>https://www.worldpharmatoday.com/drug-research/proximity-therapeutics-unlock-new-druggable-frontiers/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:52:09 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/proximity-therapeutics-unlock-new-druggable-frontiers/</guid>

					<description><![CDATA[<p>The pharmaceutical industry has historically focused on a narrow subset of the human proteome. For decades, the majority of small molecule drugs were designed to bind to the active sites of enzymes or receptors, effectively inhibiting their function. While this approach has been successful for many conditions, it is estimated that nearly eighty percent of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/proximity-therapeutics-unlock-new-druggable-frontiers/">Proximity Therapeutics Unlock New Druggable Frontiers</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI Automation Is Accelerating Drug Discovery at Scale</title>
		<link>https://www.worldpharmatoday.com/drug-research/ai-automation-is-accelerating-drug-discovery-at-scale/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:50:18 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-automation-is-accelerating-drug-discovery-at-scale/</guid>

					<description><![CDATA[<p>The traditional pharmaceutical research and development model has long been characterized by high costs, long timelines, and a high rate of failure. For every drug that successfully reaches the market, thousands of candidates fall by the wayside during the discovery and preclinical phases. This inefficiency is a significant burden on the industry, limiting the number [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/drug-research/ai-automation-is-accelerating-drug-discovery-at-scale/">AI Automation Is Accelerating Drug Discovery at Scale</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Digital Health Tools Are Transforming Patient Care Models</title>
		<link>https://www.worldpharmatoday.com/it-data-management/digital-health-tools-are-transforming-patient-care-models/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:49:28 +0000</pubDate>
				<category><![CDATA[Business & Industry]]></category>
		<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/digital-health-tools-are-transforming-patient-care-models/</guid>

					<description><![CDATA[<p>The integration of advanced technology into the clinical environment is fundamentally altering the relationship between patients, providers, and the pharmaceutical industry. For decades, the standard approach to healthcare was reactive, centralized, and episodic. Patients would visit a hospital or clinic only when symptoms became severe, and data collection was limited to what could be measured [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/it-data-management/digital-health-tools-are-transforming-patient-care-models/">Digital Health Tools Are Transforming Patient Care Models</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>AI-Driven Clinical Trials Are Closing the Speed Gap</title>
		<link>https://www.worldpharmatoday.com/clinical-trails/ai-driven-clinical-trials-are-closing-the-speed-gap/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Sat, 27 Jun 2026 07:49:01 +0000</pubDate>
				<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/ai-driven-clinical-trials-are-closing-the-speed-gap/</guid>

					<description><![CDATA[<p>The pharmaceutical industry has long struggled with the bottleneck of clinical development. While the discovery of new drug candidates has accelerated through advanced computation and genomics, the process of testing these molecules in human subjects remains slow, expensive, and prone to failure. On average, it takes over a decade and billions of dollars to bring [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/clinical-trails/ai-driven-clinical-trials-are-closing-the-speed-gap/">AI-Driven Clinical Trials Are Closing the Speed Gap</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Taste Masking Technologies Improving Oral Therapies</title>
		<link>https://www.worldpharmatoday.com/techno-trends/taste-masking-technologies-improving-oral-therapies/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 06:23:49 +0000</pubDate>
				<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/taste-masking-technologies-improving-oral-therapies/</guid>

					<description><![CDATA[<p>The primary goal of any pharmaceutical therapy is to improve patient health, but the effectiveness of even the most potent drug is entirely dependent on the patient’s willingness to take it. For oral medications, the first and often most significant hurdle is the sensory experience of the drug itself. Many active pharmaceutical ingredients (APIs) are [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/techno-trends/taste-masking-technologies-improving-oral-therapies/">Taste Masking Technologies Improving Oral Therapies</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Continuous Manufacturing Reshaping Drug Formulation</title>
		<link>https://www.worldpharmatoday.com/techno-trends/continuous-manufacturing-reshaping-drug-formulation/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 06:23:43 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Production & Manufacturing]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/continuous-manufacturing-reshaping-drug-formulation/</guid>

					<description><![CDATA[<p>Continuous manufacturing drug formulation represents the most significant leap in pharmaceutical engineering in over a century, fundamentally altering how medications are conceived, developed, and delivered to the global market. For decades, the industry operated under the batch manufacturing paradigm, a fragmented process where materials move through discrete steps mixing, granulating, drying, and compressing with long [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/techno-trends/continuous-manufacturing-reshaping-drug-formulation/">Continuous Manufacturing Reshaping Drug Formulation</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>3D Printed Dosage Forms Advancing Precision Medicine</title>
		<link>https://www.worldpharmatoday.com/techno-trends/3d-printed-dosage-forms-advancing-precision-medicine/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 06:23:05 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/3d-printed-dosage-forms-advancing-precision-medicine/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is currently witnessing a transformative shift from a mass-production model to a patient-centric approach, driven largely by the innovation of 3D printed dosage forms advancing precision medicine. For over a century, the standard of care has relied on &#8220;blockbuster&#8221; drugs produced in fixed doses, a strategy that often overlooks the profound biological [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/techno-trends/3d-printed-dosage-forms-advancing-precision-medicine/">3D Printed Dosage Forms Advancing Precision Medicine</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Real World Data Optimizing Drug Formulation Decisions</title>
		<link>https://www.worldpharmatoday.com/techno-trends/real-world-data-optimizing-drug-formulation-decisions/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Fri, 26 Jun 2026 06:22:33 +0000</pubDate>
				<category><![CDATA[Drug Research]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/real-world-data-optimizing-drug-formulation-decisions/</guid>

					<description><![CDATA[<p>The pharmaceutical industry is currently undergoing a data-driven revolution that is fundamentally changing how medications are designed and optimized. For decades, drug development was a linear process that culminated in randomized controlled trials (RCTs). While RCTs are essential for demonstrating safety and efficacy in a controlled environment, they often fail to capture the complexities of [&#8230;]</p>
The post <a href="https://www.worldpharmatoday.com/techno-trends/real-world-data-optimizing-drug-formulation-decisions/">Real World Data Optimizing Drug Formulation Decisions</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Quantum Computing Advancing Molecular Discovery Models</title>
		<link>https://www.worldpharmatoday.com/techno-trends/quantum-computing-advancing-molecular-discovery-models/</link>
		
		<dc:creator><![CDATA[Yuvraj]]></dc:creator>
		<pubDate>Mon, 22 Jun 2026 07:57:27 +0000</pubDate>
				<category><![CDATA[IT & Data Management]]></category>
		<category><![CDATA[Techno Trends]]></category>
		<guid isPermaLink="false">https://www.worldpharmatoday.com/uncategorized/quantum-computing-advancing-molecular-discovery-models/</guid>

					<description><![CDATA[<p>Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.</p>
The post <a href="https://www.worldpharmatoday.com/techno-trends/quantum-computing-advancing-molecular-discovery-models/">Quantum Computing Advancing Molecular Discovery Models</a> first appeared on <a href="https://www.worldpharmatoday.com">World Pharma Today</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
